News
RPGs How to find and use the Baldur's Gate 3 Adamantine Forge RPGs How to solve the Thorm Mausoleum painting puzzle in Baldur's Gate 3 RPGs How to open the Gnarled Door in Baldur's Gate 3 RPGs How ...
Zai Lab Limited (NASDAQ:ZLAB) and NovoCure Limited (NASDAQ:NVCR) revealed landmark results from the Phase 3 PANOVA-3 trial at the 2025 ASCO Annual Meeting, marking the first therapy to show ...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) faced a turbulent week as its shares plunged 17%, despite announcing encouraging results from a Phase 3 trial of itepekimab for chronic obstructive ...
- Complete response (CR) observed in 73% (27/37) of evaluable patients with low-grade upper tract urothelial cancer (UTUC) who completed the Induction Treatment Phase (ITP) - - Padeliporfin VTP ...
The phase, built at a cost of Rs 1,520 crore, has five metro stations, all named in the honour of prominent women -- Devi Ahilya Bai Holkar Terminal, Maharani Lakshmi Bai Station, Rani Avanti Bai ...
and NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE: PFE) today announced detailed results from the Phase 3 VERITAC-2 clinical trial (NCT05654623 ...
Regeneron Pharmaceuticals announced promising results from the Phase 3 C-POST trial of Libtayo (cemiplimab), a PD-1 inhibitor for patients with high-risk cutaneous squamous cell carcinoma (CSCC ...
One could say that the 1960s through the 1990s were a revolutionary time for music. Rock was evolving, psychedelia had come and gone, and the newer iterations of previously founded genres were ...
MCU Phase 3 raised the bar in every possible way. The fights looked better. The stakes felt heavier. The damage hit harder. These scenes didn’t just fill space between story beats. They moved ...
Cartesian Therapeutics, Inc. has announced the enrollment of the first participant in its Phase 3 AURORA trial for Descartes-08, its lead cell therapy candidate aimed at treating myasthenia gravis ...
Itepekimab met the primary endpoint in one of two COPD phase 3 studies AERIFY-1 study met its primary endpoint of a statistically significant reduction in moderate or severe exacerbations in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results